HEDS is part of the School of Health and Related Research (ScHARR) at the University of Sheffield. We undertake research, teaching, training and consultancy on all aspects of health related decision science, with a particular emphasis on health economics, HTA and evidence synthesis.

Wednesday, 4 July 2012

Recent CUAs

Twice each month the CEA Registry Blog lists recently published cost utility studies and associated papers.  14 papers were listed this time. Here's a few in our areas of research interest:

You JH, Tsui KK, Wong RS, et al. Cost-Effectiveness of Dabigatran versus Genotype-Guided Management of Warfarin Therapy for Stroke Prevention in Patients with Atrial Fibrillation. PLoS One. 2012;7(6):e39640. Epub 2012 Jun 22. PubMed PMID: 22745801.

Lee S, Anglade MW, Meng J, et al. Cost-Effectiveness of Apixaban Compared With Aspirin for Stroke Prevention in Atrial Fibrillation Among Patients Unsuitable for Warfarin. Circ Cardiovasc Qual Outcomes. 2012 Jun 26. [Epub ahead of print] PubMed PMID: 22740012.

Davidson T, Husberg M, Janzon M, et al. Cost-effectiveness of dabigatran compared with warfarin for patients with atrial fibrillation in Sweden. Eur Heart J. 2012 Jun 24. [Epub ahead of print] PubMed PMID: 22733833.